Northwestern University Feinberg School of Medicine
Research Project: Mechanisms of Chronic Allograft Dysfunction After Lung Transplant
combination therapies experimental therapeutics
While lung transplantation is a life-saving treatment for a variety of end-stage lung diseases, long-term outcomes of patients undergoing this intervention are limited due to the development of chronic lung allograft dysfunction (CLAD). This is a severe lung disease where the immune system attacks the airways of the lungs, also known as chronic rejection. We will determine whether drugs that we have shown reduce the risk of early graft injury, can reduce the risk of CLAD by reducing precluding normal repair in the lung.
Page last updated: October 3, 2023
Make a Donation
Your tax-deductible donation funds lung disease and lung cancer research, new treatments, lung health education, and more.